Every year, thousands of patients with blocked bile ducts undergo a procedure called percutaneous transhepatic cholangiodrainage, or PTCD, in which radiologists thread a needle through the liver under real-time X-ray guidance to relieve dangerous buildup of bile. The technique is lifesaving, but it comes with an unavoidable cost: radiation. Both the patient and the interventional team absorb doses during the long stretches of fluoroscopy needed to navigate catheters through dilated, often distorted bile ducts. Now a study from Beijing Friendship Hospital, Capital Medical University, published in BMC Medical Imaging, has mapped out which factors actually determine how much radiation a PTCD procedure delivers, and the results offer a practical blueprint for making these operations safer.

The research, conducted by Bowen Yang and Long Jin of the hospital’s Department of Interventional Radiology, took a deliberately multifaceted approach to the problem. Rather than relying on a single dosimetric number, the team analyzed three complementary radiation metrics in 100 patients who underwent PTCD. The first was fluoroscopy time, the total duration of live X-ray imaging during the procedure. The second was cumulative dose, which reflects the intensity of the radiation beam integrated over the exposure time. The third was dose-area product, which combines the cumulative dose with the size of the irradiated field, capturing how much tissue is exposed as well as how strongly. Each metric tells a different part of the story, and the researchers argued that only by examining all three together can clinicians understand where radiation risk truly originates.

The statistical strategy behind the study is worth appreciating, because it addresses a subtle trap in radiation research. Fluoroscopy time, cumulative dose, and dose-area product are not independent quantities. Cumulative dose is, by definition, dose rate multiplied by exposure time, and dose-area product is cumulative dose multiplied by the irradiated field area. If a researcher simply throws all three into a regression model alongside patient characteristics, the results become difficult to interpret, since the dose metrics are physically entangled with one another. Yang and Jin solved this by building a chain of multivariate generalized linear models using a Gamma distribution with a log link, a choice well suited to skewed, strictly positive dosimetric data. Fluoroscopy time was retained as a covariate in the cumulative dose model, and both fluoroscopy time and cumulative dose were retained in the dose-area product model. This allowed the team to partition the intrinsic physical contribution of exposure duration and dose intensity, so that any remaining significant factors could be interpreted as influences on each dose component beyond those mechanical relationships.

The findings on fluoroscopy time were among the most striking. Three factors emerged as significant predictors. Patients in whom the drainage was accessed via a subxiphoid route, rather than a dual approach, had substantially shorter fluoroscopy times, with the model estimating the subxiphoid route at roughly a third of the dual route’s exposure duration. Obstruction located at the hepatic hilum, as opposed to the common bile duct, was also associated with shorter fluoroscopy time, a somewhat counterintuitive result that may reflect differences in how easily guidewires and catheters can be maneuvered depending on where the blockage sits. Finally, older age predicted shorter fluoroscopy times, with each additional year of age corresponding to a small but statistically significant reduction. Taken together, these results suggest that the geometry of the access path and the location of the obstruction shape how long operators must work under continuous imaging.

When the researchers turned to cumulative dose after adjusting for fluoroscopy time, a different set of drivers came into focus. The dominant predictor was body mass index. Heavier patients absorbed markedly more radiation, with each unit increase in BMI associated with a roughly nine percent increase in cumulative dose. This makes physical sense: more tissue between the X-ray source and the detector forces the machine to increase output to penetrate the body, raising the dose delivered for every second of imaging. Female sex was associated with lower cumulative dose, and interestingly, patients with less severe intrahepatic ductal dilatation also received lower doses than those with severe dilatation, an association that reached statistical significance. Longer fluoroscopy time, unsurprisingly, remained a strong predictor of higher cumulative dose, confirming that duration and dose intensity both matter independently.

The dose-area product model, which adjusts for both fluoroscopy time and cumulative dose, told a converging story. Higher BMI again emerged as a significant predictor, as did longer fluoroscopy time and higher cumulative dose, each contributing independently to the total energy imparted across the irradiated field. Older age also predicted higher dose-area product, standing in contrast to its association with shorter fluoroscopy time. This divergence is instructive: in older patients, procedures may be quicker, but the dose delivered per unit time or per unit area can still be greater, perhaps reflecting anatomical changes or technical adjustments in beam settings. The lesson is that no single metric can stand in for the full radiation picture, and a procedure that looks efficient on one measure may still carry substantial dosimetric burden on another.

What do these findings mean in practice? The authors conclude that patient BMI is associated with overall radiation exposure, making body habitus a key variable to consider when planning and counseling patients before PTCD. Procedural complexity, reflected in the level of biliary obstruction, the choice of access route, and the severity of ductal dilatation, shows significant associations with fluoroscopy time and cumulative dose. In concrete terms, an interventional team facing an obese patient with severe ductal dilatation and a dual access plan can anticipate a higher radiation burden and take countermeasures: minimizing fluoroscopic runs, using last-image hold and other dose-saving features, collimating tightly to reduce the irradiated field area, and rotating staff positions to limit scatter exposure. Because scatter radiation to operators scales with the dose leaving the patient, every reduction in patient dose also translates into occupational protection.

The study’s design carries both strengths and limitations that readers should keep in view. Its use of three linked dosimetric metrics and a statistically careful modeling chain represents a methodological advance over single-outcome analyses, and the retrospective cohort of 100 patients from a single high-volume center provides internally consistent evidence. However, the authors themselves are explicit that these findings are exploratory and warrant validation in larger, prospective studies. A retrospective single-center design cannot capture every variable that influences radiation use, including operator experience, equipment generation, and institutional protocols, all of which may vary widely across hospitals. The effect sizes for some predictors, while statistically significant, are modest, and clinical decision-making should not rest on any single coefficient.

Even so, the study arrives at a moment when radiation safety in interventional radiology is under growing scrutiny. Procedures like PTCD are becoming more common as populations age and biliary disease burden rises, and cumulative occupational exposure among interventionalists is a persistent concern for the specialty. By identifying which patients and which procedural configurations predict the highest doses, the Beijing team has given clinicians a framework for pre-procedural radiation awareness, one that treats dosimetry not as an afterthought recorded at the end of a case but as a dimension of planning on par with access strategy and catheter selection. If larger prospective studies confirm these associations, the humble BMI measurement and the anatomical mapping performed before a needle ever touches the skin could become standard inputs into a personalized radiation risk estimate, turning routine clinical data into a shield for both patients and the physicians who treat them.

Subject of Research: Predictors of patient radiation exposure during percutaneous transhepatic cholangiodrainage

Article Title: Predictors of radiation exposure in percutaneous transhepatic cholangiodrainage: a multifactorial analysis integrating fluoroscopy time, cumulative dose, and dose-area product

Article References: Yang, B., & Jin, L. (2026). Predictors of radiation exposure in percutaneous transhepatic cholangiodrainage: a multifactorial analysis integrating fluoroscopy time, cumulative dose, and dose-area product. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02817-y

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02817-y

Keywords: PTCD, radiation protection, fluoroscopy time, cumulative dose, dose-area product, interventional radiology, BMI, biliary drainage, radiation dosimetry, generalized linear models, Predictors, radiation